Voxilaprevir reference standards and related compounds are essential tools for pharmaceutical laboratories involved in the development and quality control of this potent direct-acting antiviral agent.… Read more
Voxilaprevir reference standards and related compounds are essential tools for pharmaceutical laboratories involved in the development and quality control of this potent direct-acting antiviral agent. As a non-structural protein 3/4A (NS3/4A) protease inhibitor, Voxilaprevir is used in combination therapies to treat chronic hepatitis C virus infection by inhibiting viral replication. Our range includes high-quality reference standards, analytical materials, and stable isotope-labelled compounds required for accurate quantitative analysis. Researchers utilize these materials for impurity profiling, method validation, and structural elucidation to ensure product safety and regulatory compliance. By providing access to well-characterized Voxilaprevir impurities and metabolites, these standards support the stringent testing requirements needed throughout the pharmaceutical manufacturing lifecycle, enabling precise quantification and identification of components in complex drug matrices.